191 related articles for article (PubMed ID: 36838574)
1.
Gowtham HG; Ahmed F; Anandan S; Shivakumara CS; Bilagi A; Pradeep S; Shivamallu C; Shati AA; Alfaifi MY; Elbehairi SEI; Achar RR; Silina E; Stupin V; Murali M; Kollur SP
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838574
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design approach of potential BCL-2 inhibitors for cancer chemotherapy.
Krishna S; Kumar SB; Murthy TPK; Murahari M
Comput Biol Med; 2021 Jul; 134():104455. PubMed ID: 33962088
[TBL] [Abstract][Full Text] [Related]
4. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
Bultum LE; Tolossa GB; Lee D
PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
[TBL] [Abstract][Full Text] [Related]
5. Computational investigation of
Yousaf MA; Anwer SA; Basheera S; Sivanandan S
J Biomol Struct Dyn; 2024; 42(4):1901-1923. PubMed ID: 37154824
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking studies of bioactive compounds from Annona muricata Linn as potential inhibitors for Bcl-2, Bcl-w and Mcl-1 antiapoptotic proteins.
Mohamad Rosdi MN; Mohd Arif S; Abu Bakar MH; Razali SA; Mohamed Zulkifli R; Ya'akob H
Apoptosis; 2018 Jan; 23(1):27-40. PubMed ID: 29204721
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoinformatics-based investigation of bioactive compounds of Rasam (South Indian recipe) against human cancer.
Kalimuthu AK; Panneerselvam T; Pavadai P; Pandian SRK; Sundar K; Murugesan S; Ammunje DN; Kumar S; Arunachalam S; Kunjiappan S
Sci Rep; 2021 Nov; 11(1):21488. PubMed ID: 34728718
[TBL] [Abstract][Full Text] [Related]
9.
Sehrawat R; Rathee P; Rathee P; Khatkar S; Akkol EK; Khatkar A; Sobarzo-Sánchez E
Front Pharmacol; 2023; 14():1266833. PubMed ID: 38152692
[No Abstract] [Full Text] [Related]
10. Isolation, characterisation, anticancer and anti-oxidant activities of 2-methoxy mucic acid from
Parthiban A; Sachithanandam V; Lalitha P; Muthukumaran J; Misra R; Jain M; Sridhar R; Mageswaran T; Purvaja R; Ramesh R
J Biomol Struct Dyn; 2023 Mar; 41(4):1424-1436. PubMed ID: 34963406
[TBL] [Abstract][Full Text] [Related]
11. Docking simulation and ADMET prediction based investigation on the phytochemical constituents of Noni (
Chandran K; Shane DI; Zochedh A; Sultan AB; Kathiresan T
In Silico Pharmacol; 2022; 10(1):14. PubMed ID: 36034317
[TBL] [Abstract][Full Text] [Related]
12.
Almansour NM; Allemailem KS; Abd El Aty AA; Ismail EIF; Ibrahim MAA
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677841
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A; Kundaikar H; Degani M; Prabhu A
J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
[TBL] [Abstract][Full Text] [Related]
14. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
15. Integrated approach for studying bioactive compounds from Cladosporium spp. against estrogen receptor alpha as breast cancer drug target.
Anandan S; Gowtham HG; Shivakumara CS; Thampy A; Singh SB; Murali M; Shivamallu C; Pradeep S; Shilpa N; Shati AA; Alfaifi MY; Elbehairi SEI; Ortega-Castro J; Frau J; Flores-Holguín N; Kollur SP; Glossman-Mitnik D
Sci Rep; 2022 Dec; 12(1):22446. PubMed ID: 36575224
[TBL] [Abstract][Full Text] [Related]
16. Aphrodisiac Performance of Bioactive Compounds from
Palanichamy C; Pavadai P; Panneerselvam T; Arunachalam S; Babkiewicz E; Ram Kumar Pandian S; Shanmugampillai Jeyarajaguru K; Nayak Ammunje D; Kannan S; Chandrasekaran J; Sundar K; Maszczyk P; Kunjiappan S
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744923
[TBL] [Abstract][Full Text] [Related]
17. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
Akash S; Aovi FI; Azad MAK; Kumer A; Chakma U; Islam MR; Mukerjee N; Rahman MM; Bayıl I; Rashid S; Sharma R
PLoS One; 2023; 18(10):e0283271. PubMed ID: 37824496
[TBL] [Abstract][Full Text] [Related]
18. Venetoclax analogs as promising anticancer therapeutics via targeting Bcl-2 protein:
Almansour NM; Allemailem KS; Abd El Aty AA; Boussoufa D; Ismail Fagiree E; Ibrahim MAA
J Biomol Struct Dyn; 2023; 41(23):14308-14324. PubMed ID: 36815250
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
20. Virtual Screening of
Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
